Ra Capital Management, L.P. Design Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $1.56 Million - $3.41 Million	198,000 Added 7.14%	2,971,231 $30.5 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $8.27 Million - $15 Million	586,595 Added 26.83%	2,773,231 $46.4 Million
Q1 2021 May 17, 2021	BUY	$29.52 - $41.49 $64.5 Million - $90.7 Million	2,186,636 New	2,186,636 $65.4 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.